Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer

(2013) C.M. Nagle et al.   EUROPEAN JOURNAL OF CANCER

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

WNT5A is a Key Regulator of the Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties in Human Gastric Carcinoma Cells

(2013) Maki Kanzawa et al.   PATHOBIOLOGY

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer

(2012) H. Liang et al.   GENOME RESEARCH

Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment

(2012) Gloria Peiró et al.   HUMAN PATHOLOGY

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis

(2012) Dawne N. Shelton et al.   PLoS One

Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma

(2011) Paulette Mhawech-Fauceglia et al.   PLoS One

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

(2009) H. B. Salvesen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA